Clinical Trials Directory

Trials / Completed

CompletedNCT03989492

Role of the Sympathetic Nervous System in Rosacea

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Kristen Metzler-Wilson · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Rosacea is a common skin disorder which causes facial redness and inflammation in about 16 million Americans, from an unknown cause. Many triggers of rosacea symptoms are stressors that affect the sympathetic ("fight or flight") portion of the nervous system, and a recent pilot study suggests there is sympathetic dysfunction in rosacea. This project will benefit patients, clinicians, and basic scientists by increasing our understanding of sympathetic nervous system involvement in rosacea symptoms in order to develop improved treatments for patients with rosacea.

Conditions

Interventions

TypeNameDescription
OTHERsystemic and local stressorsProtocol 1: skin sympathetic nerve activity will be measured during mental math and handgrip exercise. Protocol 2: skin end organ responses will be measured at baseline and in response to systemic stressors and end-organ receptor stimulation. Protocol 3: skin end organ responses will be measured at baseline and during local heating.

Timeline

Start date
2019-05-24
Primary completion
2020-08-06
Completion
2020-08-06
First posted
2019-06-18
Last updated
2025-09-23

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03989492. Inclusion in this directory is not an endorsement.